Full Text
Economic burden of adverse events associated with first line Metastatic Renal Cell Carcinoma (MRCC) treatment in public and Private Brazilian Perspective

Abstract

Authors

C.N. Ferreira C.F. Santana C.S. Rufino

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×